J. Lenders, G. Eisenhofer, M. Mannelli, and K. Pacak, Phaeochromocytoma, The Lancet, vol.366, issue.9486, pp.665-675, 2005.
DOI : 10.1016/S0140-6736(05)67139-5

E. Bravo and R. Tagle, Pheochromocytoma: State-of-the-Art and Future Prospects, Endocrine Reviews, vol.24, issue.4, pp.539-553, 2003.
DOI : 10.1210/er.2002-0013

M. Mannelli, J. Lenders, K. Pacak, G. Parenti, and G. Eisenhofer, Subclinical phaeochromocytoma, Best Practice & Research Clinical Endocrinology & Metabolism, vol.26, issue.4, pp.507-515, 2012.
DOI : 10.1016/j.beem.2011.10.008

URL : http://europepmc.org/articles/pmc3413196?pdf=render

T. Cawood, P. Hunt, O. Shea, D. Cole, D. Soule et al., Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? European journal of endocrinology / European Federation of Endocrine Societies, pp.513-527, 2009.

L. Amar, A. Servais, A. Gimenez-roqueplo, F. Zinzindohoue, G. Chatellier et al., Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.4, pp.2110-2116, 2005.
DOI : 10.1210/jc.2004-1398

M. Guerrero, J. Schreinemakers, M. Vriens, I. Suh, J. Hwang et al., Clinical Spectrum of Pheochromocytoma, Journal of the American College of Surgeons, vol.209, issue.6, pp.727-732, 2009.
DOI : 10.1016/j.jamcollsurg.2009.09.022

R. Kopetschke, M. Slisko, A. Kilisli, U. Tuschy, H. Wallaschofski et al., Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma, European Journal of Endocrinology, vol.161, issue.2, pp.355-361, 2009.
DOI : 10.1530/EJE-09-0384

M. Mannelli, L. Ianni, A. Cilotti, and A. Conti, Pheochromocytoma in Italy: a multicentric retrospective study, European Journal of Endocrinology, vol.141, issue.6, pp.619-624, 1999.
DOI : 10.1530/eje.0.1410619

URL : http://www.eje-online.org/content/141/6/619.full.pdf

T. Noshiro, K. Shimizu, T. Watanabe, H. Akama, S. Shibukawa et al., Changes in clinical features and long-term prognosis in patients with pheochromocytoma, American Journal of Hypertension, vol.13, issue.1, pp.35-43, 2000.
DOI : 10.1016/S0895-7061(99)00139-9

URL : https://academic.oup.com/ajh/article-pdf/13/1/35/352170/13_1_35.pdf

P. Pigny, C. Cardot-bauters, D. Cao, C. Vantyghem, M. Carnaille et al., Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation? European journal of endocrinology / European Federation of Endocrine Societies, pp.227-231, 2009.

L. Thompson, Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.5, pp.551-566, 2002.
DOI : 10.1097/00000478-200205000-00002

V. Gardet, B. Gatta, G. Simonnet, A. Tabarin, G. Chene et al., Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma, Journal of Hypertension, vol.19, issue.6, pp.1029-1035, 2001.
DOI : 10.1097/00004872-200106000-00006

J. Vandesompele, D. Preter, K. Pattyn, F. Poppe, B. Van-roy et al., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol, vol.3, p.34, 2002.

Y. Tillet, Adrenergic neurons in sheep brain demonstrated by immunohistochemistry with antibodies to phenylethanolamine N-methyltransferase (PNMT) and dopamine-??-hydroxylase (DBH): Absence of the C1 cell group in the sheep brain, Neuroscience Letters, vol.95, issue.1-3, pp.107-112, 1988.
DOI : 10.1016/0304-3940(88)90641-6

Y. Anouar, Y. L. Desmoucelles, C. Leprince, J. Breault, L. Gallo-payet et al., Identification of a novel secretogranin II-derived peptide in the adult and fetal human adrenal gland, Endocrine Research, vol.93, issue.3-4, pp.731-736, 1998.
DOI : 10.1073/pnas.93.9.4431

M. Abramoff, P. Magelhaes, and S. Ram, Image Processing with ImageJ . Biophotonics International, vol.11, pp.36-42, 2004.

J. Lee, R. Zarnegar, W. Shen, E. Kebebew, O. Clark et al., Adrenal Incidentaloma, Borderline Elevations of Urine or Plasma Metanephrine Levels, and the ???Subclinical??? Pheochromocytoma, Archives of Surgery, vol.142, issue.9, pp.870-873, 2007.
DOI : 10.1001/archsurg.142.9.870

F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A. Masini et al., A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology, The Journal of clinical endocrinology and metabolism, vol.85, pp.637-644, 2000.

G. Eisenhofer, T. Huynh, A. Elkahloun, J. Morris, G. Bratslavsky et al., Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma, American Journal of Physiology-Endocrinology and Metabolism, vol.295, issue.5, pp.1223-1233, 2008.
DOI : 10.1016/j.neuron.2007.06.013

G. Eisenhofer, K. Pacak, T. Huynh, N. Qin, G. Bratslavsky et al., Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma, Endocrine Related Cancer, vol.18, issue.1, pp.97-111, 2011.
DOI : 10.1677/ERC-10-0211

G. Eisenhofer, M. Walther, T. Huynh, S. Li, S. Bornstein et al., Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.5, pp.1999-2008, 2001.
DOI : 10.1210/jcem.86.5.7496

URL : https://academic.oup.com/jcem/article-pdf/86/5/1999/9164059/jcem1999.pdf

A. Gimenez-roqueplo, P. Dahia, and M. Robledo, An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Hormone and metabolic research Hormonund Stoffwechselforschung Hormones et metabolisme, pp.328-333, 2012.
DOI : 10.1055/s-0031-1301302

S. Zuber, V. Kantorovich, and K. Pacak, Hypertension in Pheochromocytoma: Characteristics and??Treatment, Endocrinology and Metabolism Clinics of North America, vol.40, issue.2, pp.295-311, 2011.
DOI : 10.1016/j.ecl.2011.02.002

URL : http://europepmc.org/articles/pmc3094542?pdf=render

A. Tabarin, A. Minot, M. Dallochio, P. Roger, and D. Ducassou, Plasma concentration of neuropeptide Y in patients with adrenal hypertension, Regulatory Peptides, vol.42, issue.1-2, pp.51-61, 1992.
DOI : 10.1016/0167-0115(92)90023-N

G. Stenstrom, L. Sjostrom, and U. Smith, Diabetes mellitus in phaeochromocytoma Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma, European Journal of Endocrinology, vol.106, issue.4, pp.511-515, 1984.
DOI : 10.1530/acta.0.1060511

Y. Ito, Y. Fujimoto, and T. Obara, The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma, World Journal of Surgery, vol.30, issue.Suppl II, pp.759-764, 1992.
DOI : 10.7326/0003-4819-98-6-940

G. Eisenhofer, J. Lenders, D. Goldstein, M. Mannelli, G. Csako et al., Pheochromocytoma Catecholamine Phenotypes and Prediction of Tumor Size and Location by Use of Plasma Free Metanephrines, Clinical Chemistry, vol.51, issue.4, pp.735-744, 2005.
DOI : 10.1373/clinchem.2004.045484

URL : http://clinchem.aaccjnls.org/content/clinchem/51/4/735.full.pdf

S. Cleary, J. Phillips, T. Huynh, K. Pacak, A. Elkahloun et al., Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome, Journal of Endocrinology, vol.193, issue.2, pp.225-233, 2007.
DOI : 10.1677/JOE-06-0138

URL : http://joe.endocrinology-journals.org/content/193/2/225.full.pdf

T. Huynh, K. Pacak, F. Brouwers, M. Abu-asab, R. Worrell et al., Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2, European Journal of Endocrinology, vol.6, issue.8, pp.551-563, 2005.
DOI : 10.1002/jgm.578

URL : http://www.eje-online.org/content/153/4/551.full.pdf

N. Burnichon, L. Vescovo, L. Amar, R. Libe, A. De-reynies et al., Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma . Human molecular genetics, pp.3974-3985, 2011.
DOI : 10.1093/hmg/ddr324

URL : https://academic.oup.com/hmg/article-pdf/20/20/3974/17252976/ddr324.pdf

E. Thouennon, A. Elkahloun, J. Guillemot, A. Gimenez-roqueplo, J. Bertherat et al., Identification of Potential Gene Markers and Insights into the Pathophysiology of Pheochromocytoma Malignancy, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4865-4872, 2007.
DOI : 10.1210/jc.2007-1253

H. Timmers, A. Kozupa, G. Eisenhofer, M. Raygada, K. Adams et al., Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. The Journal of clinical endocrinology and metabolism, pp.779-786, 2007.
DOI : 10.1210/jc.2006-2315

URL : https://academic.oup.com/jcem/article-pdf/92/3/779/9051337/jcem0779.pdf

K. Pacak, G. Eisenhofer, H. Ahlman, S. Bornstein, A. Gimenez-roqueplo et al., Pheochromocytoma: recommendations for clinical practice from the First International Symposium, Nature Clinical Practice Endocrinology & Metabolism, vol.48, issue.2, pp.92-102, 2005.
DOI : 10.1007/BF03348026

M. Grumbach, B. Biller, G. Braunstein, K. Campbell, J. Carney et al., Management of the clinically inapparent adrenal mass Annals of internal medicine, pp.424-429, 2003.

A. Tabarin, S. Bardet, J. Bertherat, B. Dupas, O. Chabre et al., Exploration and management of adrenal incidentalomas., Annales d'Endocrinologie, vol.69, issue.6, pp.487-500, 2008.
DOI : 10.1016/j.ando.2008.09.003

M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani et al., AME Position Statement on adrenal incidentaloma, European Journal of Endocrinology, vol.164, issue.6, pp.851-870, 2011.
DOI : 10.1530/EJE-10-1147

URL : http://www.eje-online.org/content/164/6/851.full.pdf

G. Motta-ramirez, E. Remer, B. Herts, I. Gill, and A. Hamrahian, Comparison of CT Findings in Symptomatic and Incidentally Discovered Pheochromocytomas, American Journal of Roentgenology, vol.185, issue.3, pp.684-688, 2005.
DOI : 10.2214/ajr.185.3.01850684

D. Taieb, H. Timmers, E. Hindie, B. Guillet, H. Neumann et al., EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. European journal of nuclear medicine and molecular imaging, pp.1977-1995, 2012.

Y. Shao, R. Chen, Z. Shen, Y. Teng, P. Huang et al., Preoperative alpha blockade for normotensive pheochromocytoma, Journal of Hypertension, vol.29, issue.12, pp.2429-2432, 2011.
DOI : 10.1097/HJH.0b013e32834d24d9